Serena Williams, one of the most successful athletes of all time, has spoken out about using weight loss drugs - she says, to ...

Sara H. Jodka of Dickinson Wright PLLC discusses the legal landscape surrounding GLP-1 programs for weight loss, in light of ...

With results from highly anticipated trials of Eli Lilly’s orforglipron and Viking Therapeutics’ VK2735 “underwhelming” ...

Lil Terrio has given fans a major life update and advice on how to push through adversity. On Thursday, the 17-year-old ...

Demand for Novo Nordisk A/S’s weight-loss blockbuster Wegovy is getting a boost in the UK from an unexpected corner: ...

Eli Lilly has signed a deal worth $1.3 billion with privately held Superluminal Medicines to discover and develop ...

Glucagon-like peptide-1 (GLP-1) receptor agonists show promise in reducing cancer risk among patients with obesity, particularly for endometrial, ovarian, and meningioma cancers.

A new European obesity framework adds waist-to-height ratio and comorbidities to BMI assessment. Could this help identify ...

Obesity before pregnancy, not just during, may shape a child’s brain and raise the risk of autism spectrum disorder, a new ...

While autism itself has no single cause, researchers say their findings help us understand how early life factors can shape ...